Cruise stocks charge up more than 20% after upbeat news on Pfizer, BioNTech COVID-9 vaccine candidate

/ / News

Shares of cruise operators soared Monday, as investors cheered news that Pfizer Inc.’s and BioNTech Inc.’s COVID-19 vaccine candidate achieved “success” in an interim analysis from a Phase 3 study. Carnival Corp.’s stock rocketed 29.5% in active premarket trading, Royal Caribbean Group shares soared 21.1% and Norwegian Cruise Line Holdings Ltd. shot up 24.6%. Cruise operators have been among the hardest hit by the COVID-19 pandemic, as they have struggled to resume operations amid government restrictions in the U.S. and abroad. Investor celebration wasn’t limited to the cruise sector, as futures for the Dow Jones Industrial Average powered up more than 1,500 points, or 5.5%, ahead of the open.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.